Creative Capital Management Investments’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Creative Capital Management Investments’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128	Buy	+2	New	+$104	﹤0.01%	1422

Other funds holding KNSA

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Creative Capital Management Investments's KNSA Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 2 shares worth $128. The stake represents ﹤0.01% of the portfolio and ranks #1422 among its holdings.

35 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Creative Capital Management Investments held 2 shares of Kiniksa Pharmaceuticals worth $128 as of Q2 2026.
Kiniksa Pharmaceuticals was a new Creative Capital Management Investments position in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #1422 holding.
35 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.